Maya Ando

CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study

Manabu Funayama, Kenji Ohe, Taku Amo et al. · The Lancet Neurology · 2015 · 346 citations

Neurodegenerative Diseases, Chchd2 Mutations, Mendelian Disorder +10

(Patho‐)physiological relevance of <scp>PINK</scp> 1‐dependent ubiquitin phosphorylation

Fabienne C. Fiesel, Maya Ando, Roman Hudec et al. · EMBO Reports · 2015 · 178 citations · Full text

Protein Function, Signal Transduction, Molecular Physiology +7

Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's disease

Asako Yoritaka, Sumihiro Kawajiri, Yorihiro Yamamoto et al. · Parkinsonism & Related Disorders · 2015 · 89 citations

Neurodegenerative Diseases, Parkinson Disease, Placebo-controlled Pilot Trial +6

<i>VPS35</i> mutation in Japanese patients with typical Parkinson's disease

Maya Ando, Manabu Funayama, Yuanzhe Li et al. · Movement Disorders · 2012 · 82 citations · Full text

The PINK1 p.I368N mutation affects protein stability and ubiquitin kinase activity

Maya Ando, Fabienne C. Fiesel, Roman Hudec et al. · Molecular Neurodegeneration · 2017 · 77 citations · Full text